Please login to the form below

Not currently logged in

GSK squares up to Merck with shingles vaccine data

GSK - logo on building

Trial shows vaccine cut the risk of shingles in over 50s by 97%

Orexigen’s obesity pill Mysimba set for European approval

European Medicines Agency (EMA)But sales of the treatment are only predicted to reach $200m by 2016

'Major step forward' as EMA recommends first stem cell therapy

ChiesiBut it wants more clinical trial data to shore up the orphan drug's marketing licence

NICE backs three ulcerative colitis treatments

Johnson and Johnson J&J Simponi golimumabRemicade, Simponi and Humira recommended for NHS reimbursement

Double trial disappointment for Roche

Roche Kadcyla trastuzumab emtansine cancerDiscontinues Alzheimer’s programme and finds Kadcyla no better than Herceptin in certain breast cancer

Merck stumps up $375m for cancer firm OncoEthix

Merck and Co - US headquartersFollows $8.4bn deal to buy Cubist

Roche leads pharma R&D spend for 2013

Roche - Basel, SwitzerlandTop 30 pharma companies spent a total of $112bn on research

Pfizer teams up with snowboarder in meningitis campaign

amy purdy pfizer meningitis campaignAmy Purdy won bronze medal at 2014 Paralympic games

Amgen sets premium price for Blincyto

Amgen flagLeukaemia drug becomes one of the most expensive pharma products on the market

ScalesMaking success measurable

Companies cannot overlook effective evaluation

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Pulsar Healthcare

Pulsar Healthcare is a forward-looking, full-service creative agency, specialising in the pharmaceutical, healthcare and medical device sectors. As such, we...

Latest intelligence

UK life sciences minister George Freeman
Creating a 21st century life sciences ecosystem
The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation...
Improving Corporate Memory as a Patient Safety Strategy
An article by Lorri Zipperer...
Online Physician Communities
How can pharma innovate in child and TYA cancer?
by Dr Tim Ringrose, M3 (EU)...